Market Tracker

04/28 5:16pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

86.75
Delayed Data
As of 4:00pm ET
 +2.25 / +2.66%
Today’s Change
75.90
Today|||52-Week Range
143.45
-31.06%
Year-to-Date

Today’s Trading

Previous close84.50
Today’s open81.24
Day’s range78.84 - 90.25
Volume5,463,306
Average volume (3 months)2,439,150
Market cap$20.8B
Dividend yield--
Data as of 4:00pm ET, 04/28/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+272.66%
Earnings growth (next 5 years)+41.50%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book22.14

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-1.88-4.23%
ZTSZoetis Inc-0.27-0.57%
BMRNBiomarin Pharmaceuti...-2.62-2.99%
PRGOPerrigo Company PLC-0.79-0.81%
Data as of 4:03pm ET, 04/28/2016

Financials

Last reporting dateApril 28, 2016
EPS forecast (this quarter)$0.28
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts